A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
Conditions : Mixed Hyperlipidemia Interventions : Drug: SYH2070; Drug: Placebo Sponsors : CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. Not yet recruiting
Read the full article16h agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.